BIOSPUTNIK LLC
New York, NY · Biotech · Private
Anti-PD1 checkpoint blockade immunotherapy for lymphangioleiomyomatosis (LAM) and tuberous sclerosis (TS)
- Grants
- $857K
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20202021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Nitazoxanide as a Novel Therapy for Rare Disease Lymphangioleiomyomatosis and Tuberous Sclerosis | $256,400 | |
| Federal grant | Department of Health and Human Services · Phase I · Novel Combination Therapy for Treatment and Prevention of PulmonaryLymphangioleiomyomatosis (LAM) and Tuberous Sclerosis Complex (TSC) | $299,997 | |
| Federal grant | Department of Health and Human Services · Phase I · miRNA-Nanotechnology as a novel regenerative therapy for lymphangioleiomyomatosis | $301,016 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 1700 | OMass Therapeutics | — | — |
| 1701 | Purespring Therapeutics | — | — |
| 1702 | TEGA THERAPEUTICS INC | — | — |
| 1703 | BIOSPUTNIK LLC | — | — |
| 1704 | ONEVAX, LLC | — | — |
| 1705 | Prokaryotics, Inc. | — | — |
| 1706 | Phoenix Nest Inc. | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.